GEN Exclusives

More »

GEN News Highlights

More »
Mar 10, 2009

CTMM to Provide $319M in Funding for Eight R&D Projects in the Netherlands

CTMM to Provide $319M in Funding for Eight R&D Projects in the Netherlands

Eight Dutch R&D projects in the Netherlands to be given $319M

  • The Center for Translational Molecular Medicine (CTMM) reported it will fund eight R&D projects on new techniques for the diagnosis and treatment of major diseases with almost €250 million, or $319 million. The Dutch government will contribute half the funding, with the rest coming from the industry and academia.

    The funding will be allocated to 13 university medical centers and research institutes, 29 SMEs (small- and medium-sized enterprises), and 15 industrial organizations.

    The newly approved projects include those that target cancer as well as cardiovascular, neurodegenerative, and infectious diseases, says the center. New technology platforms such as medical imaging techniques that can be applied across a broad spectrum of these diseases will also be developed.

    The CTMM says it will also continue to invest in centralized infrastructures for company projects to address the demand for advanced genomics, proteomics, metabolomics, and bioinformatics.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Megamerger Dealzapoppin Poll

What company not in this week’s M&A headlines do you think will be at the center of a megamerger, acquisition, or partial selloff this year?